Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Phase II Study of the Hyper-CVAD Regimen in Combination with Ofatumumab (HCVAD-O) As Frontline Therapy for Adult Patients (pts) with CD20-Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Blood (2019) 134 (Supplement_1): 2577.

https://doi.org/10.1182/blood-2019-129884

Published: 2019

Journal Articles

Updated Results from the Phase II Study of Hyper-CVAD in Sequential Combination with Blinatumomab in Newly Diagnosed Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Guillaume Richard-Carpentier, MD, Hagop M. Kantarjian, MD, Nicholas J. Short, MD, Farhad Ravandi, MD, Alessandra Ferrajoli, MD, Heather M Schroeder, Guillermo Garcia-Manero, MD, Guillermo Montalban Bravo, MD, Jorge E. Cortes, MD, Monica Kwari, BSN, Christopher Loiselle, BS, Rebecca Garris, MSc, Nicole Volter, RDC, Nitin Jain, MD, Marina Y Konopleva, MD PhD, Koichi Takahashi, MD, Koji Sasaki, MD, William G. Wierda, MD PhD, Elias Jabbour, MD

Blood (2019) 134 (Supplement_1): 3807.

https://doi.org/10.1182/blood-2019-129657

Published: 2019

Journal Articles

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

Blood (2019) 134 (Supplement_1): 5072.

https://doi.org/10.1182/blood-2019-124701

Published: 2019

Journal Articles

A Refined Regimen for Maximally Eliminating Early Life-Threatening Complications for Patients with High-Risk Acute Promyelocytic Leukemia

Sanbin Wang, Lihui Peng, Lin Liu, Le Luo, Stephen Liang, MD

Blood (2018) 132 (Supplement 1): 3994.

https://doi.org/10.1182/blood-2018-99-118620

Published: 2018

Journal Articles

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

Blood (2018) 132 (Supplement 1): 5185.

https://doi.org/10.1182/blood-2018-99-116318

Published: 2018

Journal Articles

Successful Treatment with Intrathecal Tocilizumab(IL-6 antibody) for 2 Cases of Graft-Versus Host Disease of the Central Nervous System after a Second Allogeneic HSCT from Haploidentical Donor

Ruirui Gui, Juanjuan Zhao, Yingling Zu, Lu Han, MS, Yanli Zhang, Fengkuan Yu, Zhen Li, Huifang Zhao, Baijun Fang, MD, Quande Lin, Quanli Gao, MD, Yongping Song, MD, Jian Zhou, MD PhD, Delong Liu, MD PhD

Blood (2018) 132 (Supplement 1): 5730.

https://doi.org/10.1182/blood-2018-99-117725

Published: 2018

Journal Articles

A Phase II Study of the Hyper-CVAD Regimen in Sequential Combination with Blinatumomab As Frontline Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Guillaume Richard-Carpentier, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Farhad Ravandi, MD, Alessandra Ferrajoli, MD, Heather M Schroeder, Maria Khouri, Guillermo Garcia-Manero, MD, Guillermo Montalban Bravo, MD, Jorge E. Cortes, MD, Nitin Jain, MD, Marina Y. Konopleva, MD PhD, Koichi Takahashi, MD, Koji Sasaki, MD, Rebecca E. Garris, MSc, Elias J. Jabbour, MD

Blood (2018) 132 (Supplement 1): 32.

https://doi.org/10.1182/blood-2018-99-117470

Published: 2018

Journal Articles

A Cocktail Approach to Maximally Eliminating Early Mortality of Acute Promyelocytic Leukemia Patients

Stephen Yang Liang, MD

Blood (2017) 130 (Supplement 1): 5054.

https://doi.org/10.1182/blood.V130.Suppl_1.5054.5054

Published: 2017

Journal Articles

Improved Outcome with a Pediatric-Inspired Regimen for Philadelphia-Negative Acute Lymphoblastic Leukemia in the Elderly

Francois Xavier Gros, MD, Pierre-Yves Dumas, MD, Edouard Forcade, MD, Claire Calmettes, MD, Margot Robles, MD, Vincent Servant, PharmD, Nicolas Lechevalier, PharmD, Audrey Bidet, PharmD, Noel Milpied, Arnaud Pigneux, MD PhD, Thibaut Leguay, MD

Blood (2017) 130 (Supplement 1): 2560.

https://doi.org/10.1182/blood.V130.Suppl_1.2560.2560

Published: 2017

Journal Articles

Treatment Outcome of Dasatinib in Combination with Less-Intensive Induction, Homobarringtonie, Cytarabine, G-SCF in Newly Diagnosed Patients with Ph+ALL

Stephen Yang Liang, MD

Blood (2017) 130 (Supplement 1): 3882.

https://doi.org/10.1182/blood.V130.Suppl_1.3882.3882

Published: 2017

Journal Articles

Peg-Asparaginase Administration on Day 3 of Remission Induction Accelerates MRD Response in Children with B-Cell Precursor Acute Lymphoblastic Leukemia

Alexander Popov, MD PhD, Oleg Bydanov, Julia Roumiantseva, MD PhD, Svetlana Lagoiko, Mikhail Belevtsev, PhD, Elena Boyakova, MD PhD, Tatiana Verzhbitskaya, MD PhD, Liudmila Movchan, PhD, Maria Fadeyeva, MD, Natalia Migal, MD PhD, Olga Khlebnikova, MD, Natalia Miakova, MD PhD, Elena Stoliarova, MD, Olga Streneva, MD PhD, Larisa Fechina, MD PhD, Olga Aleinikova, MD PhD, Guenter Henze, MD PhD, Alexander Karachunskiy, MD PhD

Blood (2017) 130 (Supplement 1): 3983.

https://doi.org/10.1182/blood.V130.Suppl_1.3983.3983

Published: 2017

Journal Articles

Low Rates of CNS Relapse in High Risk DLBCL Patients Treated with R-CODOX-M and R-IVAC: Results from a Phase 2 UK NCRI/Bloodwise Trial

Elizabeth H Phillips, Amy A Kirkwood, Anthony Lawrie, Simon Rule, Russell Patmore, MRCP FRCPath, Ruth Pettengell, Cathy H Burton, Kirit M Ardeshna, Silvia Montoto, MD, Shankaranarayana Paneesha, Paul Smith, Katharina Wanek, Laura Clifton-Hadley, PhD BSc, David C. Linch, MD MRCP, MB BCh, BA, Andrew McMillan, PhD

Blood (2016) 128 (22): 1855.

https://doi.org/10.1182/blood.V128.22.1855.1855

Published: 2016

Journal Articles

A Prospective, Self-Controlled and Randomized Study about the Optimal Timing of Leucovorin Rescue after High Dose Methotrexate Management

Tongyu Lin, Xueying Li, Tingzhi Liu, He Huang, Huangming Hong, Chengcheng Guo, Xiaohong Fu, Xiaojie Fang, Zhao Wang, Zhongjun Xia, MD, Xiaoting Lin

Blood (2015) 126 (23): 3956.

https://doi.org/10.1182/blood.V126.23.3956.3956

Published: 2015

Journal Articles

High Event-Free Survival Rate with Minimum-Dose-Anthracycline Treatment in Childhood Acute Promyelocytic Leukemia: A Nationwide Prospective Study By the Japanese Pediatric Leukemia / Lymphoma Study Group (JPLSG)

Blood (2014) 124 (21): 956.

https://doi.org/10.1182/blood.V124.21.956.956

Published: 2014

Journal Articles

Primary Granulocytic Sarcoma of Cervix (PGSC): Review and Analysis of 13 Cases

Xuelan Zuo, Ying Wang, Yi Zhou, Lin Luo, Minghui Liu

Blood (2014) 124 (21): 5271.

https://doi.org/10.1182/blood.V124.21.5271.5271

Published: 2014

Journal Articles

Flow Cytometric Detection of Liposomes in the CSF of Patients with NHL/ALL, Treated with Intrathecal Liposomal Cytarabine: Synonymous of Toxicity?

Francisco Javier Peñalver, Martínez-Barranco Pilar, Lucía Villalón, MD, Manuel Barón, L Martín, Pilar Ricard, Karmele Arribalzaga, María José Garcia Bueno, Alberto Orfao, MD PhD

Blood (2014) 124 (21): 5444.

https://doi.org/10.1182/blood.V124.21.5444.5444

Published: 2014

Journal Articles

This Is a Title In Title Case: Safety and Efficacy of Intravenous 4.5g/m2 Methotrexate over 90 Minutes for Hematological Malignancy with Cerebral Involvement

Ling Pan, MD, PhD, Meng Chen, Li Zhang, MD, PhD, Yongqian Jia, MD, PhD, Ting Niu, MD, PhD

Blood (2013) 122 (21): 5566.

https://doi.org/10.1182/blood.V122.21.5566.5566

Published: 2013

Journal Articles

Treatment Of Non-Hodgkin’s Lymphoma With Secondary Central Nervous System Involvement: Encouraging Response Rates Using CNS-Penetrating Idaram Chemotherapy

Paul M Maciocia, MRCP, Mohsin Badat, MB BChir, Simon Cheesman, Jonathan Lambert, MD, Martin Pule, MD, David C. Linch, FRCP, Kirit M Ardeshna, FRCPath

Blood (2013) 122 (21): 4367.

https://doi.org/10.1182/blood.V122.21.4367.4367

Published: 2013

Journal Articles

Brain Lymphoma Treatment with Chemotherapy or Chemoradiotherapy from an Institution

Hassan Jalaeikhoo, MD, Bahman Shafaeean, MD, Manoutchehr Keyhani, MD

Blood (2012) 120 (21): 4859.

https://doi.org/10.1182/blood.V120.21.4859.4859

Published: 2012

Journal Articles

Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol

Blood (2012) 120 (21): 135.

https://doi.org/10.1182/blood.V120.21.135.135

Published: 2012

NARROW

Phase II Study of the Hyper-CVAD Regimen in Combination with Ofatumumab (HCVAD-O) As Frontline Therapy for Adult Patients (pts) with CD20-Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Updated Results from the Phase II Study of Hyper-CVAD in Sequential Combination with Blinatumomab in Newly Diagnosed Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

A Refined Regimen for Maximally Eliminating Early Life-Threatening Complications for Patients with High-Risk Acute Promyelocytic Leukemia

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

Successful Treatment with Intrathecal Tocilizumab(IL-6 antibody) for 2 Cases of Graft-Versus Host Disease of the Central Nervous System after a Second Allogeneic HSCT from Haploidentical Donor

A Phase II Study of the Hyper-CVAD Regimen in Sequential Combination with Blinatumomab As Frontline Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)

A Cocktail Approach to Maximally Eliminating Early Mortality of Acute Promyelocytic Leukemia Patients

Improved Outcome with a Pediatric-Inspired Regimen for Philadelphia-Negative Acute Lymphoblastic Leukemia in the Elderly

Treatment Outcome of Dasatinib in Combination with Less-Intensive Induction, Homobarringtonie, Cytarabine, G-SCF in Newly Diagnosed Patients with Ph+ALL

Peg-Asparaginase Administration on Day 3 of Remission Induction Accelerates MRD Response in Children with B-Cell Precursor Acute Lymphoblastic Leukemia

Low Rates of CNS Relapse in High Risk DLBCL Patients Treated with R-CODOX-M and R-IVAC: Results from a Phase 2 UK NCRI/Bloodwise Trial

A Prospective, Self-Controlled and Randomized Study about the Optimal Timing of Leucovorin Rescue after High Dose Methotrexate Management

High Event-Free Survival Rate with Minimum-Dose-Anthracycline Treatment in Childhood Acute Promyelocytic Leukemia: A Nationwide Prospective Study By the Japanese Pediatric Leukemia / Lymphoma Study Group (JPLSG)

Primary Granulocytic Sarcoma of Cervix (PGSC): Review and Analysis of 13 Cases

Flow Cytometric Detection of Liposomes in the CSF of Patients with NHL/ALL, Treated with Intrathecal Liposomal Cytarabine: Synonymous of Toxicity?

This Is a Title In Title Case: Safety and Efficacy of Intravenous 4.5g/m2 Methotrexate over 90 Minutes for Hematological Malignancy with Cerebral Involvement

Treatment Of Non-Hodgkin’s Lymphoma With Secondary Central Nervous System Involvement: Encouraging Response Rates Using CNS-Penetrating Idaram Chemotherapy

Brain Lymphoma Treatment with Chemotherapy or Chemoradiotherapy from an Institution

Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only